Skip to content
At CUIMC, we are committed to continuous improvement in providing culturally inclusive medical education and clinical care.
Columbia Vagelos College of Physicians and Surgeons is dedicated to developing the next generation of leaders in medicine
Search for a provider by specialty, expertise, location and insurance. Schedule an appointment online.
Read the latest news stories about CUIMC faculty, research, and events
Adana Llanos, PhD, MPH, confronts racial inequities in breast cancer and unveils the hidden impacts of chemical exposures from personal care products.
A new type of investigational therapeutic for pancreatic cancer has shown unprecedented tumor-fighting abilities in preclinical models of the disease.
Radiology is leading the way on the translation of AI tools into the clinic and cancer screening may be the first area to benefit.
A screening tool can quickly identify cancer patients at risk of financial toxicity, new findings from Columbia Nursing researchers show.
Dr. Katherine Crew found that an extract in green tea, Polyphenon E, appears to inhibit tumor cell growth, migration and invasion.
Cancer patients at NY-Presbyterian/CUMC will have access to a new free American Cancer Society program that provides resources & support.
Dr. Alfred Neugut plans to analyze how costs & other factors affect breast cancer treatment adherence--study sponsored by American Cancer Society
CUMC's Dr. Megan Sykes talks to "The Takeaway" about mouse stand-ins leading the way towards cures, treatment for patients.
Megan Sykes, a medical researcher at Columbia, has a mouse with a human immune system — her own. She calls it “Mini-Me.”
Columbia University Medical Center (CUMC) is one of 50 institutions selected nationwide from more than 700 applications for a “Provocative Questions” grant from the National Cancer Institute (NCI).
David Brenner, PhD, DSc, discusses three aspects of radiation and CT scans—quality control, training, and overuse—that urgently need addressing.
A common & aggressive brain cancer appears to be caused by a genetic mutation -- and targeting it with a drug showed promise in mice.
Some cases of glioblastoma, the most common & aggressive form of brain cancer, are caused by the fusion of 2 adjacent genes.